Trial Profile
A randomised, double-blind, placebo- and positive-controlled, three-period crossover study evaluating the effect of peginesatide on QT interval in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary) ; Moxifloxacin
- Indications Anaemia
- Focus Adverse reactions
- 28 Nov 2015 New trial record